Delayed facial weakness in Guillain-Barré and miller fisher syndromes

Muscle and Nerve

Volumn 51, Issue 6, 2015, Pages 811-814

  Tatsumoto, Muneto ^a   Misawa, Sonoko ^b   Kokubun, Norito ^a   Sekiguchi, Yukari ^b   Hirata, Koichi ^a   Kuwabara, Satoshi ^b   Yuki, Nobuhiro ^c,d  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Acute inflammatory demyelinating polyneuropathy; Acute motor axonal neuropathy; Facial palsy; Facial weakness; Guillain Barr syndrome; Miller Fisher syndrome

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; ANTIBODY; GANGLIOSIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED FACIAL WEAKNESS; DRUG EFFECT; ELECTRODIAGNOSIS; FACIAL NERVE PARALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PLASMAPHERESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VERY ELDERLY; YOUNG ADULT; BLOOD; CASE REPORT; CHI SQUARE DISTRIBUTION; CHILD; COMPLICATION; FACIAL PARALYSIS; GUILLAIN-BARRE SYNDROME; IMMUNOLOGY; MILLER FISHER SYNDROME; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ELECTRODIAGNOSIS; FACIAL PARALYSIS; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; MUSCLE WEAKNESS; YOUNG ADULT;

EID: 84929514531     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24475     Document Type: Article

References (17)

1. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-1136.
2. Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008;255:674-682.
3. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
4. Chida K, Takase S, Itoyama Y. Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases. J Neurol Neurosurg Psychiatry 1998;64:399-401.
5. Stevenson ML, Weimer LH, Bogorad IV. Development of recurrent facial palsy during plasmapheresis in Guillain-Barré syndrome: a case report. J Med Case Rep 2010;4:253.
6. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-24.
7. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978;ii:750-753.
8. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
9. Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N. Conduction block in acute motor axonal neuropathy. Brain 2010;133:2897-2908.
10. Sekiguchi Y, Uncini A, Yuki N, Misawa S, Notturno F, Nasu S, et al. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study. J Neurol Neurosurg Psychiatry 2012;83:23-28.
11. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J Neuroimmunol 1997;74:30-34.
12. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104-1106.
13. Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, et al. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes. J Neurol Neurosurg Psychiatry. 2013. [Epub ahead of print].
14. Hadden RDM, Cornblath DR, Hughes RAC, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998;44:780-788.
15. Shahrizaila N, Goh KJ, Kokubun N, Tan AH, Tan CY, Yuki N. Sensory nerves are frequently involved in the spectrum of Fisher syndrome. Muscle Nerve 2014;49:558-563.
16. Kimoto K, Koga M, Odaka M, Hirata K, Takahashi M, Li J, et al. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 2006;67:1837-1843.
17. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology 2005;65:1376-1381.